Oksana Pogoryelova

Central Parkway
Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Bis(monoacylglycero)phosphate (BMP) as a circulating biomarker of lysosomal dysfunction in GNE myopathy.

Bis(monoacylglycero)phosphate (BMP) as a circulating biomarker of lysosomal dysfunction in GNE myopathy.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 15, 2026

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use.

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use.

Journal: Annals of clinical and translational neurology

Published: April 29, 2026

Measurement of Twitch Dynamics in Response to Exercise Induced Changes in Mitochondrial Disease Using Motor Unit Magnetic Resonance Imaging (MUMRI): A Proof-of-Concept Study.

Measurement of Twitch Dynamics in Response to Exercise Induced Changes in Mitochondrial Disease Using Motor Unit Magnetic Resonance Imaging (MUMRI): A Proof-of-Concept Study.

Journal: NMR in biomedicine

Published: November 27, 2024

Ion Mobility QTOF-MS Untargeted Lipidomics of Human Serum Reveals a Metabolic Fingerprint for GNE Myopathy.

Ion Mobility QTOF-MS Untargeted Lipidomics of Human Serum Reveals a Metabolic Fingerprint for GNE Myopathy.

Journal: Molecules (Basel, Switzerland)

Published: September 27, 2024

GNE Myopathy: Genotype - Phenotype Correlation and Disease Progression in an Indian Cohort.

GNE Myopathy: Genotype - Phenotype Correlation and Disease Progression in an Indian Cohort.

Journal: Journal of neuromuscular diseases

Published: August 30, 2024

Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation.

Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation.

Journal: Brain : a journal of neurology

Published: March 06, 2024

NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.

NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.

Journal: Brain : a journal of neurology

Published: July 20, 2021

Results from a 3-year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy.

Results from a 3-year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy.

Journal: Journal of neuromuscular diseases

Published: January 18, 2021

Economic Costs of Myasthenia Gravis: A Systematic Review.

Economic Costs of Myasthenia Gravis: A Systematic Review.

Journal: PharmacoEconomics

Published: May 05, 2020

237th ENMC International Workshop: GNE myopathy - current and future research Hoofddorp, The Netherlands, 14-16 September 2018.

237th ENMC International Workshop: GNE myopathy - current and future research Hoofddorp, The Netherlands, 14-16 September 2018.

Journal: Neuromuscular disorders : NMD

Published: February 19, 2019

GNE genotype explains 20% of phenotypic variability in GNE myopathy.

GNE genotype explains 20% of phenotypic variability in GNE myopathy.

Journal: Neurology. Genetics

Published: September 07, 2018

A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy.

A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy.

Journal: Neurology

Published: July 25, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026